Godavari Drugs Limited (BOM:530317)

Market Cap	639.19M
Revenue (ttm)	1.05B
Net Income (ttm)	37.90M
Shares Out	7.53M
EPS (ttm)	5.03
PE Ratio	16.87
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,633
Average Volume	3,634
Open	82.60
Previous Close	85.07
Day's Range	82.00 - 87.70
52-Week Range	78.91 - 133.90
Beta	0.03
RSI	60.63
Earnings Date	Nov 14, 2025

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 106
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530317

Financial Performance

In 2024, Godavari Drugs's revenue was 1.14 billion, a decrease of -27.42% compared to the previous year's 1.57 billion. Earnings were 43.80 million, a decrease of -21.07%.